Ofatumumab is a feasible alternative anti-CD20 therapy in patients intolerant of rituximab
BRITISH JOURNAL OF HAEMATOLOGY（2019）
关键词
lymphoma,rituximab,ofatumumab,monoclonal antibody,infusion-related reaction
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要